MetaADEDB 2.0 @ LMMD
Irbesartan
(YOSHYTLCDANDAN-UHFFFAOYSA-N)
Structure
SMILES
CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2
Type(s)
Approved; Investigational
ATC code(s)
C09CA04; C09DA04; C09DB05
Molecular Formula:
C25H28N6O
Molecular Weight:
428.529
Log P:
4.1509
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
87.13
CAS Number(s):
138402-11-6
Synonym(s)
1.
Irbesartan
2.
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
3.
Aprovel
4.
Avapro
5.
BMS 186295
6.
BMS-186295
7.
Karvea
8.
SR 47436
9.
SR-47436
10.
SR47436
External Link(s)
MeSHD000077405
PubChem Compound3749
BindingDB50042235
ChEBI5959
CHEMBLCHEMBL1513
DrugBankDB01029
DrugCentral1481
IUPHAR/BPS Guide to PHARMACOLOGY6908
589
KEGGcpd:C07469
dr:D00523
Therapeutic Target DatabaseD00JAU
D0F8KG
ZINC3872931
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 180
Canada Vigilance: 21
Canada Vigilance
US FAERS
2DizzinessFAERS: 90
Canada Vigilance: 17
Canada Vigilance
SIDER
US FAERS
3DysgeusiaFAERS: 88SIDER
US FAERS
4HeadacheFAERS: 85
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
5FatigueFAERS: 66
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
6NauseaFAERS: 61
Canada Vigilance: 13
Canada Vigilance
OFFSIDES
SIDER
US FAERS
7MalaiseFAERS: 53
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
8Product substitution issueFAERS: 42
Canada Vigilance: 50
Canada Vigilance
US FAERS
9Adverse eventFAERS: 38US FAERS
10HypotensionFAERS: 38
Canada Vigilance: 1
16164579
18182475
CTD
SIDER
Canada Vigilance
US FAERS
11MyalgiaFAERS: 37
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
12AlopeciaFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
13AngioedemaFAERS: 31
Canada Vigilance: 3

View details

CTD
SIDER
Canada Vigilance
US FAERS
14AstheniaFAERS: 30
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
15Feeling abnormalFAERS: 28
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
16Medication ErrorFAERS: 27US FAERS
17PalpitationsFAERS: 27
Canada Vigilance: 3
Canada Vigilance
US FAERS
18Weight decreasedFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
19Chest PainFAERS: 25
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
20Abdominal PainFAERS: 24
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
21HypersensitivityFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22AnxietyFAERS: 23SIDER
US FAERS
23UrticariaFAERS: 23
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24PruritusFAERS: 21
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
25Product quality issueFAERS: 20US FAERS
26VomitingFAERS: 20
Canada Vigilance: 6
18182475CTD
SIDER
Canada Vigilance
US FAERS
27Abdominal discomfortFAERS: 19
Canada Vigilance: 4
Canada Vigilance
US FAERS
28NervousnessFAERS: 19SIDER
US FAERS
29ArthralgiaFAERS: 18
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
30Blood pressure inadequately controlledFAERS: 18
Canada Vigilance: 12
Canada Vigilance
US FAERS
31Wrong technique in product usage processFAERS: 18US FAERS
32Blood creatinine increasedFAERS: 16US FAERS
33Cerebrovascular accidentFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34DyspepsiaFAERS: 16
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
35PainFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36Chest discomfortFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
37TinnitusFAERS: 14SIDER
US FAERS
38Blood pressure fluctuationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
39Burning sensationFAERS: 13US FAERS
40Wrong technique in drug usage processFAERS: 13US FAERS
41Acute kidney injuryFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Erectile dysfunctionFAERS: 12US FAERS
43ErythemaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
44FlushingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
45SomnolenceFAERS: 12SIDER
US FAERS
46Blood potassium increasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
47Drug abuseFAERS: 11US FAERS
48Joint swellingFAERS: 11US FAERS
49Blood creatine phosphokinase increasedFAERS: 10SIDER
US FAERS
50ConstipationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
51PresyncopeFAERS: 10US FAERS
52Toxicity to various agentsFAERS: 10US FAERS
53TremorFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
54Blood glucose increasedFAERS: 9US FAERS
55DeafnessFAERS: 9US FAERS
56Drug dispensing errorFAERS: 9US FAERS
57EpistaxisFAERS: 9SIDER
US FAERS
58PregnancyFAERS: 9US FAERS
59jaundiceFAERS: 9SIDER
US FAERS
60Back PainFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
61Incorrect dose administeredFAERS: 8US FAERS
62Urinary tract infectionFAERS: 8SIDER
US FAERS
63VasculitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
64Accidental exposure to product by childFAERS: 7US FAERS
65CataractFAERS: 7US FAERS
66DysphoniaFAERS: 7OFFSIDES
US FAERS
67FlatulenceFAERS: 7SIDER
US FAERS
68HepatitisFAERS: 7SIDER
US FAERS
69Musculoskeletal PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
70Musculoskeletal stiffnessFAERS: 7OFFSIDES
SIDER
US FAERS
71Myocardial InfarctionFAERS: 7
Canada Vigilance: 2
21229253CTD
SIDER
Canada Vigilance
US FAERS
72No adverse eventFAERS: 7US FAERS
73Product taste abnormalFAERS: 7US FAERS
74Throat irritationFAERS: 7US FAERS
75Unevaluable eventFAERS: 7US FAERS
76Acute myocardial infarctionFAERS: 6US FAERS
77AgeusiaFAERS: 6US FAERS
78Blood sodium decreasedFAERS: 6US FAERS
79Depressed moodFAERS: 6US FAERS
80Drug dose omissionFAERS: 6US FAERS
81EnteritisFAERS: 6US FAERS
82Eye painFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
83GastritisFAERS: 629523851CTD
US FAERS
84NeutropeniaFAERS: 6SIDER
US FAERS
85OverdoseFAERS: 6OFFSIDES
US FAERS
86RhabdomyolysisFAERS: 6SIDER
US FAERS
87Sprue-like enteropathyFAERS: 6US FAERS
88SyncopeFAERS: 618182475CTD
SIDER
US FAERS
89Therapeutic response unexpectedFAERS: 6US FAERS
90VertigoFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
91AgitationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
92AnosmiaFAERS: 5OFFSIDES
US FAERS
93Apparent life threatening eventFAERS: 5US FAERS
94AsthmaFAERS: 5SIDER
US FAERS
95Blood triglycerides increasedFAERS: 5US FAERS
96BradycardiaFAERS: 5OFFSIDES
SIDER
US FAERS
97ChillsFAERS: 5SIDER
US FAERS
98DysuriaFAERS: 5OFFSIDES
US FAERS
99GlaucomaFAERS: 5US FAERS
100LethargyFAERS: 5US FAERS
101Leukocytoclastic vasculitisFAERS: 5SIDER
US FAERS
102Limb discomfortFAERS: 5US FAERS
103Lip swellingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
104MalabsorptionFAERS: 5US FAERS
105SwellingFAERS: 5SIDER
US FAERS
106Visual ImpairmentFAERS: 5SIDER
US FAERS
107Atrial FibrillationFAERS: 421545815CTD
US FAERS
108BronchitisFAERS: 4US FAERS
109ChokingFAERS: 4OFFSIDES
US FAERS
110ChromaturiaFAERS: 4SIDER
US FAERS
111Cold sweatFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
112ColitisFAERS: 4US FAERS
113Diabetes MellitusFAERS: 4SIDER
US FAERS
114DiplopiaFAERS: 4US FAERS
115DiscomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
116Ear discomfortFAERS: 4US FAERS
117Erythema MultiformeFAERS: 4US FAERS
118Gamma-Glutamyltransferase IncreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Gastric ulcerFAERS: 4OFFSIDES
US FAERS
120Head discomfortFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
121Hypertensive crisisFAERS: 4SIDER
US FAERS
122LeukopeniaFAERS: 4SIDER
US FAERS
123NephrolithiasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Oropharyngeal blisteringFAERS: 4US FAERS
125Oropharyngeal painFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Peripheral swellingFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
127Recalled product administeredFAERS: 4US FAERS
128Stevens-Johnson SyndromeFAERS: 4US FAERS
129Suicide attemptFAERS: 4US FAERS
130Suspected counterfeit productFAERS: 4US FAERS
131Urinary RetentionFAERS: 4US FAERS
132Vascular purpuraFAERS: 4US FAERS
133Visual disturbanceFAERS: 4SIDER
US FAERS
134Accidental overdoseFAERS: 3US FAERS
135Alanine Aminotransferase IncreasedFAERS: 3US FAERS
136Angina PectorisFAERS: 3SIDER
US FAERS
137Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
138Blood glucose decreasedFAERS: 3OFFSIDES
US FAERS
139Blood potassium abnormalFAERS: 3US FAERS
140Blood product transfusion dependentFAERS: 3US FAERS
141BronchiolitisFAERS: 3US FAERS
142Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
143CyanosisFAERS: 3US FAERS
144DehydrationFAERS: 3OFFSIDES
US FAERS
145DementiaFAERS: 3US FAERS
146Drug administration errorFAERS: 3OFFSIDES
US FAERS
147Ear congestionFAERS: 3US FAERS
148FractureFAERS: 3US FAERS
149General physical health deteriorationFAERS: 3US FAERS
150Joint injuryFAERS: 3US FAERS
151Joint stiffnessFAERS: 3SIDER
US FAERS
152LeukocytosisFAERS: 3US FAERS
153Medication residueFAERS: 3US FAERS
154Memory impairmentFAERS: 3US FAERS
155NasopharyngitisFAERS: 3SIDER
US FAERS
156PneumoniaFAERS: 3SIDER
US FAERS
157Product solubility abnormalFAERS: 3US FAERS
158Product use issueFAERS: 3US FAERS
159Pulmonary congestionFAERS: 3SIDER
US FAERS
160Rash erythematousFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
161Renal cystFAERS: 3OFFSIDES
US FAERS
162ShockFAERS: 316164579CTD
SIDER
US FAERS
163StomatitisFAERS: 3US FAERS
164Supraventricular tachycardiaFAERS: 3US FAERS
165ThrombocytopeniaFAERS: 3SIDER
US FAERS
166White blood cell count decreasedFAERS: 3US FAERS
167Wrong drug administeredFAERS: 3US FAERS
168AbasiaFAERS: 2US FAERS
169Acute Coronary SyndromeFAERS: 2OFFSIDES
SIDER
US FAERS
170Air EmbolismFAERS: 2OFFSIDES
US FAERS
171AnorexiaFAERS: 2SIDER
US FAERS
172ArthropathyFAERS: 2US FAERS
173Autoimmune hepatitisFAERS: 2US FAERS
174Blood cholesterol increasedFAERS: 2US FAERS
175Blood creatine increasedFAERS: 2OFFSIDES
US FAERS
176Blood creatine phosphokinase MB increasedFAERS: 2US FAERS
177Blood urea increasedFAERS: 2SIDER
US FAERS
178Burning Mouth SyndromeFAERS: 2US FAERS
179Cardiac ArrestFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
180Cardiac discomfortFAERS: 2US FAERS
181Creatinine renal clearance decreasedFAERS: 2US FAERS
182Decompression SicknessFAERS: 2US FAERS
183Depressed Level of ConsciousnessFAERS: 2US FAERS
184DisabilityFAERS: 2US FAERS
185DiverticulitisFAERS: 2US FAERS
186Dry skinFAERS: 2US FAERS
187Extra dose administeredFAERS: 2US FAERS
188Eye irritationFAERS: 2US FAERS
189Facial paralysisFAERS: 2US FAERS
190Food AllergyFAERS: 2US FAERS
191GastroenteritisFAERS: 2SIDER
US FAERS
192Gastrointestinal carcinomaFAERS: 2US FAERS
193GingivitisFAERS: 2US FAERS
194HepatotoxicityFAERS: 2US FAERS
195HerniaFAERS: 2OFFSIDES
US FAERS
196HyperthyroidismFAERS: 2US FAERS
197Impaired driving abilityFAERS: 2US FAERS
198Impaired work abilityFAERS: 2US FAERS
199IncontinenceFAERS: 2US FAERS
200InfarctionFAERS: 2US FAERS
201InflammationFAERS: 2US FAERS
202Intentional product misuseFAERS: 2US FAERS
203Macular degenerationFAERS: 2US FAERS
204MastitisFAERS: 2US FAERS
205MicroalbuminuriaFAERS: 2US FAERS
206Muscle tightnessFAERS: 2US FAERS
207Musculoskeletal chest painFAERS: 2SIDER
US FAERS
208MyopiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
209Neck PainFAERS: 2US FAERS
210Nephrotic SyndromeFAERS: 2US FAERS
211Occupational exposure to drugFAERS: 2US FAERS
212Ocular HypertensionFAERS: 2US FAERS
213PancytopeniaFAERS: 2US FAERS
214PetechiaeFAERS: 2US FAERS
215Polymyalgia RheumaticaFAERS: 2US FAERS
216Product physical issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Product size issueFAERS: 2US FAERS
218Pulmonary EmbolismFAERS: 2US FAERS
219Pulmonary FibrosisFAERS: 2US FAERS
220Restless Legs SyndromeFAERS: 2US FAERS
221RestlessnessFAERS: 2US FAERS
222RhinitisFAERS: 2SIDER
US FAERS
223Septic ShockFAERS: 2US FAERS
224Sexual DysfunctionFAERS: 2SIDER
US FAERS
225SinusitisFAERS: 2US FAERS
226Skin lesionFAERS: 2US FAERS
227SneezingFAERS: 2US FAERS
228Spermatozoa morphology abnormalFAERS: 2US FAERS
229Squamous cell carcinomaFAERS: 2US FAERS
230StressFAERS: 2SIDER
US FAERS
231TachyarrhythmiaFAERS: 2US FAERS
232TachycardiaFAERS: 2SIDER
US FAERS
233ThirstFAERS: 2US FAERS
234Urine output increasedFAERS: 2US FAERS
235WheezingFAERS: 2SIDER
US FAERS
236nervous system disorderFAERS: 2SIDER
US FAERS
237Accidental drug intake by childFAERS: 1US FAERS
238Accidental exposure to productFAERS: 1US FAERS
239Amaurosis FugaxFAERS: 1US FAERS
240AmnesiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
241Anaphylactic shockFAERS: 1SIDER
US FAERS
242AneurysmFAERS: 1US FAERS
243AngerFAERS: 1US FAERS
244Angiotensin converting enzyme increasedFAERS: 1US FAERS
245Angle Closure GlaucomaFAERS: 1US FAERS
246Ankle FractureFAERS: 1US FAERS
247Anorectal discomfortFAERS: 1US FAERS
248Aortic AneurysmFAERS: 1OFFSIDES
US FAERS
249AphagiaFAERS: 1US FAERS
250AphasiaFAERS: 1US FAERS
251AphoniaFAERS: 1US FAERS
252ArteritisFAERS: 1OFFSIDES
US FAERS
253ArthritisFAERS: 1SIDER
US FAERS
254AsphyxiaFAERS: 1US FAERS
255Back disorderFAERS: 1US FAERS
256BedriddenFAERS: 1US FAERS
257Bladder cystFAERS: 1US FAERS
258Bladder spasmFAERS: 1US FAERS
259BlepharospasmFAERS: 1US FAERS
260BlindnessFAERS: 1SIDER
US FAERS
261Blood alkaline phosphatase increasedFAERS: 1US FAERS
262Blood cholesterol abnormalFAERS: 1US FAERS
263Blood electrolytes decreasedFAERS: 1US FAERS
264Blood magnesium increasedFAERS: 1US FAERS
265Blood potassium decreasedFAERS: 1US FAERS
266Blood urine presentFAERS: 1US FAERS
267Bone painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
268BronchiectasisFAERS: 1US FAERS
269Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
270Carbon dioxide increasedFAERS: 1US FAERS
271Cardiac FlutterFAERS: 1US FAERS
272Carpal Tunnel SyndromeFAERS: 1US FAERS
273Caustic injuryFAERS: 1US FAERS
274Cerebral artery stenosisFAERS: 1US FAERS
275CholestasisFAERS: 1US FAERS
276ClinodactylyFAERS: 1US FAERS
277Completed SuicideFAERS: 1US FAERS
278Coronary Artery DiseaseFAERS: 1US FAERS
279CryingFAERS: 1US FAERS
280CystitisFAERS: 1US FAERS
281CytopeniaFAERS: 1US FAERS
282Deep Vein ThrombosisFAERS: 1US FAERS
283Dental cariesFAERS: 1US FAERS
284Device interactionFAERS: 1US FAERS
285Device malfunctionFAERS: 1US FAERS
286Diabetes mellitus inadequate controlFAERS: 1US FAERS
287Drug exposure during pregnancyFAERS: 1US FAERS
288Drug prescribing errorFAERS: 1US FAERS
289Drug resistanceFAERS: 1US FAERS
290DysarthriaFAERS: 1US FAERS
291DysphemiaFAERS: 1US FAERS
292Ejection fraction abnormalFAERS: 1US FAERS
293Electrocardiogram abnormalFAERS: 1US FAERS
294Emotional disorderFAERS: 1SIDER
US FAERS
295EnuresisFAERS: 1US FAERS
296ErythrosisFAERS: 1US FAERS
297ExcoriationFAERS: 1US FAERS
298Expired drug administeredFAERS: 1US FAERS
299Eye RednessFAERS: 1US FAERS
300Facial PainFAERS: 1US FAERS
301Feeling ColdFAERS: 1OFFSIDES
SIDER
US FAERS
302Feeling jitteryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
303FormicationFAERS: 1US FAERS
304Full blood count decreasedFAERS: 1US FAERS
305Gastric hypertoniaFAERS: 1US FAERS
306GastroduodenitisFAERS: 1US FAERS
307Gastrointestinal PainFAERS: 1SIDER
US FAERS
308Gastrointestinal infectionFAERS: 1US FAERS
309Gastrointestinal motility disorderFAERS: 1US FAERS
310Gestational DiabetesFAERS: 1US FAERS
311Gingival HyperplasiaFAERS: 1US FAERS
312Guillain-Barre SyndromeFAERS: 1US FAERS
313Heart sounds abnormalFAERS: 1US FAERS
314HepatomegalyFAERS: 1US FAERS
315HyperkeratosisFAERS: 1US FAERS
316HypogonadismFAERS: 1US FAERS
317HypothyroidismFAERS: 1US FAERS
318Idiopathic angioedemaFAERS: 1US FAERS
319Impaired gastric emptyingFAERS: 1US FAERS
320Incorrect product administration durationFAERS: 1US FAERS
321Incorrect product storageFAERS: 1US FAERS
322InfertilityFAERS: 1US FAERS
323Inflammatory painFAERS: 1US FAERS
324InfluenzaFAERS: 1SIDER
US FAERS
325Insulin ResistanceFAERS: 1US FAERS
326Intentional product use issueFAERS: 1US FAERS
327Intercepted drug dispensing errorFAERS: 1US FAERS
328Intestinal ObstructionFAERS: 1US FAERS
329Keratoconjunctivitis SiccaFAERS: 1US FAERS
330LazinessFAERS: 1US FAERS
331Ligament ruptureFAERS: 1US FAERS
332Live BirthFAERS: 1US FAERS
333Lower respiratory tract infectionFAERS: 1US FAERS
334Lumbar herniaFAERS: 1US FAERS
335Lupus-like syndromeFAERS: 1US FAERS
336MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
337Metabolic acidosisFAERS: 1US FAERS
338MetamorphopsiaFAERS: 1US FAERS
339MetastasisFAERS: 1US FAERS
340Migraine with AuraFAERS: 1US FAERS
341Multi-organ disorderFAERS: 1US FAERS
342Muscle CrampFAERS: 1US FAERS
343MyelofibrosisFAERS: 1US FAERS
344MyopathyFAERS: 1US FAERS
345Nasal PolypsFAERS: 1US FAERS
346Nephrogenic Diabetes InsipidusFAERS: 1US FAERS
347Nerve injuryFAERS: 1US FAERS
348NeuralgiaFAERS: 1US FAERS
349Night sweatsFAERS: 1US FAERS
350NoduleFAERS: 1US FAERS
351Non-cardiac chest painFAERS: 1US FAERS
352Nonspecific reactionFAERS: 1US FAERS
353Ocular icterusFAERS: 1US FAERS
354Opiates positiveFAERS: 1US FAERS
355PallorFAERS: 1US FAERS
356Pancreatic enzymes increasedFAERS: 1US FAERS
357PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
358Periorbital swellingFAERS: 1US FAERS
359Peripheral venous diseaseFAERS: 1US FAERS
360Personality ChangeFAERS: 1US FAERS
361Pharyngolaryngeal PainFAERS: 1US FAERS
362PhotophobiaFAERS: 1US FAERS
363PneumonitisFAERS: 1US FAERS
364PoisoningFAERS: 1US FAERS
365PolymyositisFAERS: 1US FAERS
366PolyuriaFAERS: 1US FAERS
367Pre-EclampsiaFAERS: 1US FAERS
368Prescribed overdoseFAERS: 1US FAERS
369Procedural complicationFAERS: 1US FAERS
370Product availability issueFAERS: 1US FAERS
371Product coating issueFAERS: 1US FAERS
372Product counterfeitFAERS: 1US FAERS
373Product dose omissionFAERS: 1US FAERS
374Product formulation issueFAERS: 1US FAERS
375Product friableFAERS: 1US FAERS
376Product package associated injuryFAERS: 1US FAERS
377Product use complaintFAERS: 1US FAERS
378Productive CoughFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
379Protein total increasedFAERS: 1US FAERS
380Pruritus allergicFAERS: 1US FAERS
381PsoriasisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
382PterygiumFAERS: 1US FAERS
383Pulmonary HypertensionFAERS: 1US FAERS
384QuadriplegiaFAERS: 1US FAERS
385Rash scalyFAERS: 1US FAERS
386Reaction to drug excipientsFAERS: 1US FAERS
387Reaction to excipientFAERS: 1US FAERS
388Renal painFAERS: 1US FAERS
389Renin abnormalFAERS: 1US FAERS
390Renin increasedFAERS: 1US FAERS
391Respiratory FailureFAERS: 1US FAERS
392Respiratory arrestFAERS: 1US FAERS
393Respiratory distressFAERS: 1SIDER
US FAERS
394RetchingFAERS: 1US FAERS
395RetrognathiaFAERS: 1US FAERS
396Retroperitoneal fibrosisFAERS: 1US FAERS
397RosaceaFAERS: 1US FAERS
398SarcoidosisFAERS: 1US FAERS
399Secretion dischargeFAERS: 1US FAERS
400Skin UlcerFAERS: 1US FAERS
401Skin WrinklingFAERS: 1US FAERS
402Skin lacerationFAERS: 1US FAERS
403SluggishnessFAERS: 1US FAERS
404Sperm count decreasedFAERS: 1US FAERS
405Spinal cord herniationFAERS: 1US FAERS
406Suspected product contaminationFAERS: 1US FAERS
407Therapeutic product contaminationFAERS: 1US FAERS
408Therapy changeFAERS: 1US FAERS
409Thermal burnFAERS: 1US FAERS
410Thirst decreasedFAERS: 1US FAERS
411ThrombosisFAERS: 1US FAERS
412Thrombotic strokeFAERS: 1US FAERS
413Tongue blisteringFAERS: 1US FAERS
414Tongue discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
415TonsillectomyFAERS: 1US FAERS
416Tooth ErosionFAERS: 1US FAERS
417Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
418Transaminases increasedFAERS: 1US FAERS
419UlcerFAERS: 1US FAERS
420Umbilical herniaFAERS: 1US FAERS
421Urinary IncontinenceFAERS: 1US FAERS
422Urinary tract inflammationFAERS: 1US FAERS
423Uterine CancerFAERS: 1US FAERS
424VIIth nerve paralysisFAERS: 1US FAERS
425Venous InsufficiencyFAERS: 1US FAERS
426Venous occlusionFAERS: 1US FAERS
427Venous thrombosis limbFAERS: 1US FAERS
428Vitamin D DeficiencyFAERS: 1US FAERS
429Walking aid userFAERS: 1US FAERS
430Wheelchair userFAERS: 1US FAERS
431Wound dehiscenceFAERS: 1US FAERS
432muscle injuryFAERS: 1US FAERS
433prostatitisFAERS: 1US FAERS
434pseudomembranous colitisFAERS: 1US FAERS
435Abdominal InfectionOFFSIDES
436Acid refluxOFFSIDES
437AcidosisOFFSIDES
438Agitation postoperativeOFFSIDES
439AgranulocytosisSIDER
440Albuminuria11508272CTD
441Amylase increasedCanada Vigilance: 1Canada Vigilance
442Anemia17216246CTD
443AngioplastyOFFSIDES
444AnhedoniaOFFSIDES
445AnhidrosisOFFSIDES
446Animal biteOFFSIDES
447AnoxiaOFFSIDES
448Antidepressant drug level above therapeuticOFFSIDES
449Antipsychotic drug level increasedOFFSIDES
450Aortic valve calcificationOFFSIDES
451Application site discomfortOFFSIDES
452Application site urticariaOFFSIDES
453Arterial bruitOFFSIDES
454Atherosclerosis19028402CTD
455Atrial hypertrophyOFFSIDES
456Atrial rhythmSIDER
457Atrial tachycardiaOFFSIDES
458Atrioventricular BlockOFFSIDES
459Azotemia14728886CTD
460BlepharitisOFFSIDES
461Blood pH decreasedOFFSIDES
462Blood pressure immeasurableOFFSIDES
463Blood sodiumOFFSIDES
464Body TemperatureOFFSIDES
465Bone density decreasedOFFSIDES
466Breast FeedingSIDER
467Bronchial irritationCanada Vigilance: 1Canada Vigilance
468Brown urineSIDER
469BursitisCanada Vigilance: 1Canada Vigilance
SIDER
470Cardiomegaly9118530CTD
471Carotid bruitOFFSIDES
472CellulitisOFFSIDES
473Cerebral artery occlusionOFFSIDES
474Cerebral atrophyOFFSIDES
475Cervicobrachial syndromeOFFSIDES
476Chemical and Drug Induced Liver Injury14733885CTD
477Choking sensationOFFSIDES
478Chronic respiratory failureOFFSIDES
479Common ColdSIDER
480Congenital tricuspid valve incompetenceOFFSIDES
481ConjunctivitisSIDER
482Coordination disturbanceSIDER
483Creatine Phosphokinase IncreasedSIDER
484Deafness NeurosensoryOFFSIDES
485Delirium18182475CTD
486DermatitisCanada Vigilance: 1Canada Vigilance
SIDER
487Diabetic FootOFFSIDES
488Diabetic Neuropathies14586737CTD
489Diabetic RetinopathyOFFSIDES
490DiabeticSIDER
491Diarrhea18182475CTD
OFFSIDES
492DistentionSIDER
493DiverticulumOFFSIDES
494DysgraphiaOFFSIDES
495Ear and labyrinth disordersSIDER
496EcchymosisSIDER
497Electrolyte imbalanceSIDER
498Emotional distressOFFSIDES
499Endomyocardial Fibrosis21545815CTD
500Eosinophilia16943303CTD
501Epigastric discomfortSIDER
502Epigastric painSIDER
503ErysipelasOFFSIDES
504Essential HypertensionOFFSIDES
SIDER
505Febrile NeutropeniaOFFSIDES
506Fibrosis15149348CTD
507Flank PainCanada Vigilance: 1Canada Vigilance
OFFSIDES
508Foaming at mouthOFFSIDES
509Gastric irritationSIDER
510General disorders and administration site conditionsSIDER
511General symptomOFFSIDES
512Glomerulonephritis9848785CTD
513GlycosuriaSIDER
514GoutSIDER
515GranulocytosisOFFSIDES
516HaemoconcentrationOFFSIDES
517Heart failure10750252CTD
518HeartburnSIDER
519HemiparesisOFFSIDES
520HydrocephalusOFFSIDES
521InfectionOFFSIDES
SIDER
522Infectious MononucleosisOFFSIDES
523Intention tremorOFFSIDES
524Internal injuryOFFSIDES
525Intestinal Diseases19077729CTD
526Jaundice, Obstructive23956101CTD
527Joint abscessOFFSIDES
528Kidney Diseases9407464
15101793
CTD
529Kidney Failure, Chronic11104169
11765585
CTD
530Kidney FailureOFFSIDES
531Labyrinthine disorderSIDER
532LeukoplakiaOFFSIDES
533LightheadednessSIDER
534Livedo ReticularisOFFSIDES
535Long QT Syndrome18182475CTD
536LymphopeniaSIDER
537MalnutritionSIDER
538Mastication disorderOFFSIDES
539MeningiomaOFFSIDES
540MonoparesisSIDER
541MonoplegiaOFFSIDES
542Mood swingsSIDER
543Multiple MyelomaOFFSIDES
544Musculoskeletal discomfortSIDER
545MyositisSIDER
546NephrectomyOFFSIDES
547Nephritis, Interstitial16943303CTD
548Neutropenic colitisOFFSIDES
549NumbnessSIDER
550Occult blood positiveOFFSIDES
551Ocular discomfortCanada Vigilance: 1Canada Vigilance
552OliguriaOFFSIDES
553OnychoclasisCanada Vigilance: 1Canada Vigilance
554Oral lesionSIDER
555PanniculitisOFFSIDES
556PapuleCanada Vigilance: 1Canada Vigilance
557Performance status decreasedOFFSIDES
558Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
559PharyngitisSIDER
560PhlebitisOFFSIDES
561PingueculaOFFSIDES
562Pneumococcal sepsisOFFSIDES
563Product lot number issueCanada Vigilance: 1Canada Vigilance
564Progesterone receptor assayOFFSIDES
565Protein urine presentSIDER
566Proteinuria12969165
15149348
15685505
CTD
SIDER
567PurpuraCanada Vigilance: 1Canada Vigilance
568Relapsing FeverOFFSIDES
569Renal Artery StenosisOFFSIDES
570Renal Insufficiency15685505CTD
571Respiratory tract congestionSIDER
572Restrictive cardiomyopathyOFFSIDES
573Scotoma16362652CTD
574Sensation of warmthSIDER
575Sick Sinus SyndromeOFFSIDES
576Sinus bradycardiaOFFSIDES
577Sinus headacheCanada Vigilance: 1Canada Vigilance
578Skin discomfortSIDER
579SoporOFFSIDES
580Spinal column stenosisOFFSIDES
581StiffnessSIDER
582Subcutaneous AbscessOFFSIDES
583Substance Withdrawal Syndrome20428619CTD
584Swelling of limbSIDER
585Systolic hypertensionOFFSIDES
586Tension HeadacheOFFSIDES
587TensionSIDER
588Therapeutic response changedCanada Vigilance: 1Canada Vigilance
589Thromboembolic strokeOFFSIDES
590Tooth LossOFFSIDES
591Tooth repairOFFSIDES
592ToxoplasmosisOFFSIDES
593TracheobronchitisSIDER
594TraumaSIDER
595Upper airway obstructionOFFSIDES
596Urethral StenosisOFFSIDES
597Ventricular Remodeling16635409CTD
598Ventricular arrhythmiaSIDER
599VertebroplastyOFFSIDES
600Vestibular NeuronitisOFFSIDES
601Weight GainOFFSIDES
602XanthopsiaSIDER
603bad tasteSIDER
604skin abrasionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.